Inherent genome instability underlies trisomy 21-associated myeloid malignancies-Reference-Cited by-同舟云学术

Inherent genome instability underlies trisomy 21-associated myeloid malignancies

Published:2024-01-20 Issue:3 Volume:38 Page:521-529
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Chen Chun-Chin,Silberman Rebecca E.,Ma Duanduan,Perry Jennifer A.,Khalid Delan,Pikman Yana^ORCID,Amon Angelika,Hemann Michael T.^ORCID,Rowe R. Grant^ORCID

Funder

U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases

Leukemia and Lymphoma Society

Alex's Lemonade Stand Foundation for Childhood Cancer

U.S. Department of Health & Human Services | NIH | National Cancer Institute

Howard Hughes Medical Institute

The Alana Down Syndrome Center at MIT.

The MIT Center for Precision Cancer Medicine. The Ludwig Center at MIT.

St. Baldrick's Foundation

Hannah's Heroes Foundation

Publisher

Springer Science and Business Media LLC

Link

https://www.nature.com/articles/s41375-024-02151-8.pdf

Reference50 articles.

1. Marlow EC, Ducore J, Kwan ML, Cheng SY, Bowles EJA, Greenlee RT, et al. Leukemia Risk in a Cohort of 3.9 Million Children with and without Down Syndrome. J Pediatr. 2021;234:172–80 e3.

2. Roberts I, Alford K, Hall G, Juban G, Richmond H, Norton A, et al. GATA1-mutant clones are frequent and often unsuspected in babies with Down syndrome: identification of a population at risk of leukemia. Blood. 2013;122:3908–17.

3. Wechsler J, Greene M, McDevitt MA, Anastasi J, Karp JE, Le Beau MM, et al. Acquired mutations in GATA1 in the megakaryoblastic leukemia of Down syndrome. Nat Genet. 2002;32:148–52.

4. Labuhn M, Perkins K, Matzk S, Varghese L, Garnett C, Papaemmanuil E, et al. Mechanisms of progression of myeloid preleukemia to transformed myeloid leukemia in children with down syndrome. Cancer Cell. 2019;36:123–38.e10.

5. Laurent AP, Kotecha RS, Malinge S. Gain of chromosome 21 in hematological malignancies: lessons from studying leukemia in children with Down syndrome. Leukemia. 2020;34:1984–99.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. DNA damage repair in megakaryopoiesis: molecular and clinical aspects;Expert Review of Hematology;2024-08-13

2. The hematopoietic microenvironment of the fetal liver and transient abnormal myelopoiesis associated with Down syndrome: A review;Critical Reviews in Oncology/Hematology;2024-07

3. Malignant progression of preleukemic disorders;Blood;2024-05-30